impact factor, citescore
logo
 

Clinical and Experimental Rheumatology is a monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983. The journal includes annual monothematic issues on the following topics:

The monothematic issue on Myositis is also the official organ of the International Myositis Society (iMyoS, https://imyos.org).

Articles submitted on these topics, once accepted are published ahead-of-print online, and subsequently included in the correspondent monothematic issue.

Editor-in-Chief
Stefano Bombardieri, MD

Environmental Rheumatology

LER & CER: Letter to the Editor Rheumatology

Letter to Editor Rheumatology: Commentaries and Controversies (LER) has been an online forum for a stronger voice and a wider audience for critical and dissenting views in rheumatology and related disciplines. It has joined forces with Clinical and Experimental Rheumatology to achieve the deserved wider audience.

Letters can be submitted solely to: https://www.clinexprheumatol.org, please read Authors’ Guidelines.

Page charge

A page charge of €130.00 will be assessed for all articles published. Instructions for payment will be sent to authors along with the proofs. There is no charge for solicited articles.

Education and CME

 

last archive

Quality

The 5 most viewed PDFs in the last 7 days
in press from 6 months ago (One year in review excluded)

From 09/03/2025 to 16/03/2025

CER18287
Free to view
118 click

The classification of myositis: setting the stage for a universal terminology
M. Giannini, S. Bhai, O. Boyer, K. Cheng, M. Johari, P. Korsten, J.B. Lilleker, D. Saygin, S. Schlüter, A.J. Van Der Kooi, J. Schmidt
on behalf of the International Myositis Society (iMyoS)

Rheumatology Abstract

 

CER18124
Free to view
83 click

An update on myositis autoantibodies and insights into pathogenesis
G. Wang, N.J. Mchugh

Rheumatology Abstract

 

CER17836
Free to view
61 click

Triple-combination therapy did not improve prognosis in anti-MDA5 positive dermatomyositis: a multicentre longitudinal cohort study
H. You, C. Lv, L. Xu, L. Wang, T. Liu, F. Yuan, W. Yan, H. Wei, J. Wang, D. Meng, W. Tan

Rheumatology Abstract

 

CER18316
Free to view
51 click

Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale
U.A. Badrising, R. Henderson, S. Reddel, A. Corbett, C. Liang, K. Reardon, R. Ghaoui, M. Bulsara, S. Brady, A. Brusch, D. Chan, J.D. Coudert, T. Fairchild, G. Jain, M.C. Kiernan, D. Leonard, T. Lloyd, J. Schmidt, M.P. Mcdermott, L. Sanders, C. Lowe, A.J.

Rheumatology Abstract

 

CER18436
Free to view
50 click

The myositis landscape in clinical trials: 2025 and beyond
G. Zanframundo, V. Codullo, L. Cavagna

Rheumatology Abstract

 

The 5 most viewed Abstracts in the last 7 days
in press from 6 months ago (One year in review excluded)

From 09/03/2025 to 16/03/2025

CER17808
Free to view
756 click

A charter to improve care for systemic lupus erythematosus
M. Mosca, J. Andersen, P. Wildman, S. Manzi, Z. Amoura, I. Bultink, O.A. Monticielo, S. Navarra, S. Pettersson

Rheumatology Abstract

 

CER18316
Free to view
191 click

Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale
U.A. Badrising, R. Henderson, S. Reddel, A. Corbett, C. Liang, K. Reardon, R. Ghaoui, M. Bulsara, S. Brady, A. Brusch, D. Chan, J.D. Coudert, T. Fairchild, G. Jain, M.C. Kiernan, D. Leonard, T. Lloyd, J. Schmidt, M.P. Mcdermott, L. Sanders, C. Lowe, A.J.

Rheumatology Abstract

 

CER18287
Free to view
157 click

The classification of myositis: setting the stage for a universal terminology
M. Giannini, S. Bhai, O. Boyer, K. Cheng, M. Johari, P. Korsten, J.B. Lilleker, D. Saygin, S. Schlüter, A.J. Van Der Kooi, J. Schmidt
on behalf of the International Myositis Society (iMyoS)

Rheumatology Abstract

 

CER18342
Free to view
120 click

The Myositis Clinical Trials Consortium: an international collaborative initiative to promote clinical trials in adult and juvenile myositis
A. Bishnoi, I.Y.K. Tang, A. Yoshida, F.M. Pais, S.Y. Usman, S.A. Dominguez, C.G. Kavadichanda, D. Rivero-Gallegos, E. Dourado, E. Conticini, F. Bozán, G. Tulluru, J.B. Lilleker, K. Sreerama Reddy, O. Landon-Cardinal, R. Smaili, S. Keret, T. Khoo, T.-Y. La

Rheumatology Abstract

 

CER18573
Free to view
119 click

Quantitative muscle magnetic resonance imaging as a biomarker for inclusion body myositis in clinical trials: exploring the in vivo effects of arimoclomol
S. Salam, J.M. Morrow, M.P. Mcdermott, N. Zafeiropoulos, J.S. Thornton, S. Shah, S. Wastling, T.Y. Yousry, R.J. Barohn, M.G. Hanna, M.M. Dimachkie, P.M. Machado

Rheumatology Abstract